Search results
Results from the WOW.Com Content Network
If the patient is 'low risk' using the CHA 2 DS 2-VASc score (that is, 0 in males or 1 in females), no anticoagulant therapy is recommended. In males with 1 stroke risk factor (that is, a CHA 2 DS 2-VASc score=1), antithrombotic therapy with OAC may be considered, and people's values and preferences should be considered. [24]
[1] [2] Its usefulness was questioned in a 2015 review as it was not found to separate those who are at low from those who are at high risk of future problems. [3] A high score correctly predicted 87% of the people who did have a stroke in the following 7 days but also many people who did not have problems. [3]
When it comes to stroke prevention, the guideline stresses the need for risk assessment—including with a risk assessment calculator that estimates 10-year and 30-year stroke and heart disease ...
“Stroke remains a leading cause of disability and death globally, with many cases linked to modifiable risk factors. Current risk prediction models rely heavily on invasive tests like blood ...
The most significant risk factor for stroke is high blood pressure. [7] Other risk factors include high blood cholesterol, tobacco smoking, obesity, diabetes mellitus, a previous TIA, end-stage kidney disease, and atrial fibrillation. [2] [7] [8] Ischemic stroke is typically caused by blockage of a blood vessel, though there are also less ...
The most common presentation of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a hemorrhagic stroke. [2] Hypertension (high blood pressure) is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis . [ 5 ]
Centers for Disease Control (CDC): “Risk Factors for Stroke” American Heart Association : “Stroke Risk Factors, Genetics, and Prevention” American Stroke Association : “Stroke Symptoms”
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...